Indication

Effectiveness

1 clinical trial

1 product

Clinical trial

A Multicenter, Open, One-arm Phase II Study of Ranvastinib Mesylate Capsules in the Treatment of Advanced Bone and Soft Tissue Sarcoma After Chemotherapy Failure

Status: Recruiting, Estimated PCD: 2026-12-31

Product